Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
Clinical trial NCT01111305 · COMPLETED
Trial details
- NCT number
- NCT01111305
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2016-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.